Skip to content
Article Rich – Lifestyle
Author:
Solid Biosciences Inc.
Solid Biosciences Provides Interim Positive Clinical Update on Phase 1/2 INSPIRE DUCHENNE Trial
March 11, 2026
Solid Biosciences to Present at the 2026 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
March 6, 2026
Solid Biosciences Announces Oversubscribed $240 Million Private Placement
March 6, 2026
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 5, 2026
←
Previous Page
1
2